Illumina Picks Genomic Health’s Phil Febbo for Chief Medical Officer

Xconomy San Diego — 

Illumina (NASDAQ: ILMN) has appointed Phil Febbo to serve as chief medical officer of the San Diego genomics technologies company. Febbo most recently worked as chief medical officer of Redwood City, CA-based Genomic Health (NASDAQ: GHDX). Before that, he was a professor of medicine and urology at the University of California, San Francisco.